Diagnostic dilemmas in Epstein-Barr virus hepatitis mimicking autoimmune hepatitis: A case report

Diagnostic dilemmas in Epstein-Barr virus hepatitis mimicking autoimmune hepatitis: A case report

We report a case of 55-year-old female with chief complaints of fever and deranged liver function tests, diagnosed as autoimmune hepatitis (AIH) and under immunosuppressive therapy for two years. Following the failure in clinical improvement, she was started on anti-tubercular therapy (ATT). While i...

Full description

Bibliographic Details
Main Authors:	Krithiga Ramachandran, Reshu Agarwal, Chhagan Bihari, Vikram Bhatia, Ekta Gupta
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Journal of Family Medicine and Primary Care
Subjects:	chronic active ebv hodgkin's lymphoma immunosuppressive medications
Online Access:	http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=5;spage=2502;epage=2504;aulast=Ramachandran

Similar Items

Molecular Characterisation of Epstein–Barr Virus in Classical Hodgkin Lymphoma
by: Valerija Begić, et al.
Published: (2022-12-01)

Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France
by: Marie Donzel, et al.
Published: (2022-12-01)

Epstein-Barr virus: Ubiquitous virus with multifarious implication in oral diseases
by: Koumpouli Alexandra, et al.
Published: (2024-01-01)

Differences in Epstein-Barr Virus Characteristics and Viral-Related Microenvironment Could Be Responsible for Lymphomagenesis in Children
by: Aldana Vistarop, et al.
Published: (2020-01-01)

Relationship between Non-Hodgkin’s lymphoma and blood levels of Epstein-Barr Virus in children in north-western Tanzania: a case control study
by: Kabyemera Rogatus, et al.
Published: (2013-01-01)

Epstein-Barr virus DNA in serum in a HIV-infected patient during development and treatment of non-Hodgkin's lymphoma
by: F Fleisch, et al.
Published: (2005-05-01)

The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers
by: Alison Felipe Bordini Biggi, et al.
Published: (2022-03-01)

Epstein Barr Virus-Associated Hodgkin Lymphoma
by: Antonino Carbone, et al.
Published: (2018-05-01)

IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
by: Helen Heslop, et al.
Published: (2009-11-01)

Superiority of Epstein-Barr Virus DNA in the Plasma Over Whole Blood for Prognostication of Extranodal NK/T Cell Lymphoma
by: Joo Young Ha, et al.
Published: (2020-11-01)

MicroRNA and Other Non-Coding RNAs in Epstein–Barr Virus-Associated Cancers
by: Kin Israel Notarte, et al.
Published: (2021-08-01)

Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
by: Katerina Vrzalikova, et al.
Published: (2018-08-01)

INFECTIONS CAUSED BY EPSTEIN-BARR VIRUS IN HIV-INFECTED PATIENTS
by: L. V. Puzyreva, et al.
Published: (2016-12-01)

Epstein–Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis
by: Ahmed El-Sharkawy, et al.
Published: (2018-08-01)

Primary hepatic lymphoma- A diagnostic dilemma
by: Purushotham Reddy, et al.
Published: (2022-01-01)

Epstein–Barr virus mucocutaneous ulcer followed by Hodgkin lymphoma in multiple myeloma patient
by: Moriah Forster, et al.
Published: (2022-03-01)

Epstein-Barr virus: the molecular virology and the associated diseases
by: Takayuki Murata
Published: (2023-05-01)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
by: Wook Youn Kim, et al.
Published: (2019-03-01)

Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL
by: Mahdi Nohtani, et al.
Published: (2022-09-01)

Epstein-Barr Virus-Positive Lymphomas Exploit Ectonucleotidase Activity To Limit Immune Responses and Prevent Cell Death
by: Philip T. Lange, et al.
Published: (2023-04-01)

Primary hepatic Epstein–Barr virus-positive diffuse large B-cell lymphoma associated with azathioprine immunosuppression: a case report
by: Paulina S. Marell, et al.
Published: (2023-05-01)

Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV+ Patients
by: Diana M. Hernández, et al.
Published: (2018-10-01)

Relationship between Epstein-Barr Virus (EBV) Infection and Viral Load in Immunosuppressive Patients
by: Meryem Çolak, et al.
Published: (2018-03-01)

Anaplastic T cell lymphoma in a patient with autoimmune hepatitis and hepatitis C infection
by: Hina Ismail, et al.
Published: (2021-07-01)

Editorial: Epstein-Barr virus and its contribution to pediatric tumors
by: Paola Chabay, et al.
Published: (2022-09-01)

Measurement of Levels of Ebstein-Barr Virus Antibodies in Patients with Hodgkins Lymphoma and Comparison with Normal Population
by: M Mortazavi-zadeh, et al.
Published: (2004-07-01)

Chronic Epstein-Barr virus infection causing both benign and malignant lymphoproliferative disorders
by: Yoojin Kwun, et al.
Published: (2014-09-01)

Are Selected Cytokines and Epstein–Barr Virus DNA Load Predictors of Hepatological Complications of Epstein–Barr Virus Infection in Children?
by: Justyna Moppert, et al.
Published: (2023-09-01)

A rare case of three distinct Epstein-Barr virus associated lymphoproliferative disorders over sixteen years of human immunodeficiency virus infection
by: Hamdy M.A. Ahmed, et al.
Published: (2017-06-01)

Epstein–Barr Virus-Positive Mucocutaneous Ulcer: A Unique and Curious Disease Entity
by: Tomoka Ikeda, et al.
Published: (2021-01-01)

Hodgkin Lymphoma Mimicking Osteomyelitis
by: Aneela Majeed, et al.
Published: (2017-06-01)

Prevalence of hepatitis delta virus infection among hepatitis B virus-infected and exposed patients
by: Krithiga Ramachandran, et al.
Published: (2020-01-01)

Epstein–Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas
by: Pier P. Piccaluga, et al.
Published: (2018-06-01)

Virological Markers in Epstein–Barr Virus-Associated Diseases
by: Julien Lupo, et al.
Published: (2023-02-01)

Epstein–Barr Virus-Associated T- and NK-Cell Lymphoproliferative Diseases: A Review of Clinical and Pathological Features
by: Charlotte Syrykh, et al.
Published: (2021-07-01)

Identification and validation of an immunological microenvironment signature and prediction model for epstein-barr virus positive lymphoma: Implications for immunotherapy
by: Chenjiao Yao, et al.
Published: (2022-09-01)

Epstein-Barr virus in children with classical Hodgkin’s lymphoma
by: I V Botezatu, et al.
Published: (2018-03-01)

Epstein–Barr Virus in Inborn Immunodeficiency—More Than Infection
by: Ciro Novaes Rosa Lino, et al.
Published: (2021-09-01)

Disc‐like lesions in the intestinal tract after renal transplantation
by: Arjan J. Kwakernaak, et al.
Published: (2022-04-01)

Epidemiology of Epstein-Barr virus-associated pediatric lymphomas from Argentina
by: Paola Chabay, et al.
Published: (2016-01-01)